SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-031085
Filing Date
2017-05-09
Accepted
2017-05-09 14:01:11
Documents
1
Period of Report
2017-05-05

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3581
  Complete submission text file 0001104659-17-031085.txt   5123
Mailing Address C/O ARCA BIOPHARMA, INC 8001 ARISTA PLACE, STE 430 BROOMFIELD CO 80021
Business Address
CONWAY ROBERT E (Reporting) CIK: 0001184334 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 17825730

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1